Medytox Inc.

Medytox Inc. operates as a pharmaceutical company producing botulinum toxin, hyaluronic acid filler and other related products.It is a company studying the time of humankind. Medytox is a global leader in botulinum toxin industry. Since the launch of botulinum toxin type A Meditoxin in 2006, Medytox has shown a dramatic growth. Medytox reached 40% of market share in Korea since 2009 and is expected to increase even further with various indications being included.The global botulinum toxin market continues to grow and is expected to further expand to not only medical aesthetics market but also therapeutic market. Medytox will grow as the leader of the biopharmaceutical industry by challenging ourselves with passion for the global market.

SHOW 1 PIECES RESET ALL FILTERS

Innotox

Innotox is a type A botulinum toxin developed by the South Korean company Medytox Inc. It is the world's first liquid injectable form of botulinum Toxin type A approved by KFDA in South Korea, in 2013. Allergan, the Botox manufacturer, made an exclusive license agreement to market Innotox worldwide, excluding Korea and Japan. It is produced in compliance with all international GRM standards and the conditions for the production of biological substances.

Innotox 50ui

50ui

1 - 1 of 1 results

Shop By Category

A

B

D

E

F

H

I

J

L

A

B

D

E

F

H

I

J

L

M

N

P

A

B

C

D

G

H

I

L

M

N

P

Medytox Inc.

Filter

Innotox

Innotox 50ui